• Home
  • Patients
  • Medical Professionals
  • Company
    • Press Release
    • Management
    • Development Timeline
  • Contact Us
Subchondral Solutions | Revolutionizing Joint Repair
  • Home
  • Patients
  • Medical Professionals
  • Company
    • Press Release
    • Management
    • Development Timeline
  • Contact Us

DEVELOPMENT 
​TIMELINE

Picture
  • Final S-Core™ Device Design, Manufacturing and Regulatory Validations completed. 
  • ​Thomas Kinder joins company as C.E.O.
  • ​Andy Carter, Phd Biologics joins company as an advisor.
Picture
  • S-Core™ receives 510(k) Clearance September 2017
  • Pilot Study completed for the Bioactive​ S-Core™ Implant System September 2017
  • Doctor's Brian Snyder, Eric Strauss and Marc Safran join the Scientific Advisory Board March 2017
  • U.S. issues Method and Device for Ameliorating Joint Conditions and Diseases Methods Patent issued January 2017
  • Australia issues Method and Device for Ameliorating Joint Conditions
    and Diseases Patent June 2017
  • ​Series A1 investment round closed.
Picture
  • Pilot Study completed for the Bio-mechanical S-Core™ Implant December 2015
  • U.S. Methods Patent issued October 2015
  • Hong Kong Issues Joint Support and Subchondral Support System Patent July 2015
  • Subchondral Solutions completes Series A financing July 2015
  • U.S. issues Method and Device for Ameliorating Joint Conditions and Diseases Patent March 2015
Picture
  • John Tighe, CEO of Zipline, joins the Advisory Board 
    Subchondral Solutions, Inc. is formed.
​    Co-Founders
    Derek Dee, MD - Chief Medical Officer
    Thay Lee, Phd - Chief Science Officer
    Sheryl McCoy - Chief Financial Officer
    Chris Maurer - Chief Technology Officer
Picture
  • First Case in Human May 2020
  • Post-Operative clinical data​ collection started
  • Q3 - Controlled Market Launch (U.S. Only)
  • Q4 - Full Market Launch​ (U.S. Only)
  • Successful MCRA Marketing Regulatory Review
  • New FDA Clearance "Minimally Invasive reconstruction of fractures and joints" along with additional size implants Range Now Includes 4mm-10mm
  • FDA Clearance for the use of Hydroxyapatite Coating on all size Implants 
Picture






​

  • European issues Method and Device for Ameliorating Joint Conditions and Diseases Patent April 2018
​
Picture
  • Japan issues Method and Device for Amerliorating Joint – Conditions and Diseases Patent September 2016
  • Steven Arnoczky, DVM joins the Scientific Advisory Board July 2016
Picture
  • U.S. issues Joint Support and Subchondral Support System – Methods Patent November 2014
  • China issues Joint Support and Subchondral Support – System Patent November 2014
  • Dr. Nathaniel Cohen joins the Scientific – Advisory Board July 2014
  • U.S. issues Joint Support and Subchondral – Support System Patent June 2014
  • Co-Founder Thay Lee, PhD Keynote Speaker for the – Athroscopy Association of America’s Annual Meeting May 2014
Picture
Singapore issues Joint Support and Subchondral
Support System Patent June 2012

DEVELOPMENT TIMELINE

© 2021 Subchondral Solutions Inc. All Rights Reserved
  • Home
  • Patients
  • Medical Professionals
  • Company
    • Press Release
    • Management
    • Development Timeline
  • Contact Us